a bad rap

This mob of Portuguese analysts have never been too keen on BLT and this is their current assessment.

"Report Summary: Benitec Biopharma Ltd is a low quality company with a neutral outlook. Benitec Biopharma Ltd has weak business growth and is run by inefficient management. The trend in Benitec Biopharma Ltd fair value exchange rate against its closest rated-competitor, Circadian Technologies Limited, has been appreciating over the past 2 weeks. When compared to its closest competitor, Benitec Biopharma Ltd shows less overvaluation and is equally likely to underperform the market."

http://reports.pr-inside.com/sadif-analytics-upgraded-benitec-biopharma-r3567023.htm

This is what happens when you apply pure numbers to the research and don't look at the things that numbers cannot tell you, BLT's potential. No one in there right mind would buy BLT on the numbers. We are all waiting for the potential so the value of report like these has to be questioned. However, this info in now in the public domain and it could influence some possible investors.